Search Results - "Walt, Anneke van der"

High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients by Dwyer, Christopher M., Jokubaitis, Vilija G., Stankovich, Jim, Baker, Josephine, Haartsen, Jodi, Butzkueven, Helmut, Cartwright, Adriana, Shuey, Neil, Fragoso, Yara Dadalti, Rath, Louise, Skibina, Olga, Fryer, Kylie, Butler, Ernest, Coleman, Jennifer, MacIntrye, Jennifer, Macdonell, Richard, Walt, Anneke van der

“…Aims: To retrospectively assess factors associated with John Cunningham virus (JCV) seroconversion in natalizumab-treated patients. Background: Natalizumab is…”
Get full text

The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis by Merlo, Daniel, Darby, David, Kalincik, Tomas, Butzkueven, Helmut, van der Walt, Anneke

“…Background: Multiple sclerosis (MS) cognitive tests are resource intensive and limited by practice effects that prevent frequent retesting. Brief, reliable and…”
Get full text

A 20-year multicentre retrospective review of optic nerve sheath fenestration outcomes by El-Masri, Shaddy, Wilson, Matthew, Goh, Jonathan, Sanfilippo, Paul, Fok, Anthony, Hardy, Thomas, Chakrabarti, Rahul, Van Der Walt, Anneke

“…Background: Optic nerve sheath fenestration (ONSF) longitudinal outcomes remain unclear and are vital in the assessment of vision failure in patients with…”
Get full text

3 Managing disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis by Lizak, Nathaniel, Sharmin, Sifat, Walt, Anneke Van der, Butzkueven, Helmut, Lechner-Scott, Jeanette, Buzzard, Katherine, Skibina, Olga, Hodgkinson, Suzanne, Slee, Mark, John, Nevin, Roos, Izanne, Kalincik, Tomas

“…Background/ObjectivesFailure of natalizumab to control disease activity in multiple sclerosis (MS) is an uncommon event. It is currently unknown whether…”
Get full text

3138 Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis by Roos, Izanne, Sharmin, Sifat, Malpas, Charles, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Walt, Anneke Van der, Butzkueven, Helmut, Buzzard, Katherine, Skibina, Olga, John, Nevin, Barnett, Michael, Kalincik, Tomas

“…Background/ObjectivesCladribine reduces the frequency of relapses by 57% and disability worsening by 33% compared to placebo in relapsing-remitting multiple…”
Get full text

2967 Utilisation of high efficacy therapy for managing multiple sclerosis in Australia by McCombe, Pamela, Butzkueven, Helmut, Samjoo, Imtiaz, Barnett, Michael, Broadley, Simon, Walt, Anneke Van der, Merschhemke, Martin, Adlard, Nicholas, Burke, Naomi, Riley, Nicholas, Walker, Rob

“…BackgroundOfatumumab is a self-administered disease modifying therapy (DMT) approved in Australia for relapsing multiple sclerosis (RMS). We have previously…”
Get full text

3149 Real-world Australian experience with Ofatumumab in the MSBase registry by Migocki, Margaret, Walt, Anneke Van der, Butzkueven, Helmut, Spelman, Tim, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William M, Lechner-Scott, Jeannette, John, Nevin, Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Kalincik, Tomas, Macdonell, Richard, Slee, Mark, Schmitt, Birte

“…ObjectivesTo characterize the use of ofatumumab (OFA), a fully human self-administered anti-CD20 monoclonal antibody, in a real-world setting in Australia by…”
Get full text

3115 Longitudinal trajectories of digital cognitive biomarkers for multiple sclerosis by Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Zhu, Chao, Buzzard, Katherine, Lechner-Scott, Jeannette, Barnett, Michael, Taylor, Bruce, Kalincik, Tomas, Kilpatrick, Trevor, Darby, David, Dobay, Pamela, Beek, Johan van, Hyde, Robert, Butzkueven, Helmut, Walt, Anneke van der

“…BackgroundCognitive impairment is one of the most common and debilitating symptoms of relapsing remitting multiple sclerosis (RRMS). Digital cognitive…”
Get full text

3116 Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis by Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Zhu, Chao, Buzzard, Katherine, Lechner-Scott, Jeannette, Barnett, Michael, Taylor, Bruce, Kalincik, Tomas, Kilpatrick, Trevor, Darby, David, Dobay, Pamela, Beek, Johan van, Hyde, Robert, Butzkueven, Helmut, Walt, Anneke van der

“…BackgroundUpper limb dysfunction is a common debilitating feature of relapsing remitting multiple sclerosis (RRMS). We aimed to examine the longitudinal…”
Get full text

The MSBase pregnancy, neonatal outcomes, and women’s health registry by Jokubaitis, Vilija G., Skibina, Olga, Alroughani, Raed, Altintas, Ayse, Butzkueven, Helmut, Eichau, Sara, Fragoso, Yara, Hellwig, Kerstin, Hughes, Stella E., Rath, Louise, van der Walt, Anneke, Gray, Orla

“…Background: Family planning and pregnancy decisions are key considerations in the management of women with multiple sclerosis (MS), who are typically diagnosed…”
Get full text

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe by Nicholas, Richard, Rodgers, Jeff, Witts, James, Lerede, Annalaura, Friede, Tim, Hillert, Jan, Forsberg, Lars, Glaser, Anna, Manouchehrinia, Ali, Ramanujam, Ryan, Spelman, Tim, Klyve, Pernilla, Drahota, Jiri, Horakova, Dana, Joensen, Hanna, Pontieri, Luigi, Magyari, Melinda, Ellenberger, David, Stahmann, Alexander, Butzkueven, Helmut, Van Der Walt, Anneke, Bezlyak, Vladimir, Lines, Carol, Middleton, Rod

“…Introduction: Prescribing guidance for disease-modifying treatment (DMT) in multiple sclerosis (MS) is centred on a clinical diagnosis of relapsing–remitting…”
Get full text

021 Relationships between Cognitive Impairment and Clinical Features of Idiopathic Intracranial Hypertension by Wang, Wendy, Clough, Meaghan, White, Owen, Shuey, Neil, Walt, Anneke Van der, Fielding, Joanne

“…ObjectiveTo determine whether cognitive impairments in patients with Idiopathic Intracranial Hypertension (IIH) are correlated with changes in visual…”
Get full text

100 Developing a quality assurance framework for neuro-ophthalmology referrals using NODE – the neuro-ophthalmology database by Lal, Anoushka, Roche, Olga, White, Owen, Wang, Wendy, Sheth, Shivanand, Chakrabarti, Rahul, Porto, Lana del, Fok, Anthony, Shuey, Neil, Fraser, Clare, Kowal, Lionel, Walt, Anneke Van der

“…ObjectiveQuality assurance (QA) in neuro-ophthalmology (NOPH) is often lacking. The QA registry, NODE (Neuro-ophthalmology Database), was established and…”
Get full text

011 Worsening longitudinal reaction time trajectories using the MSReactor computerised battery predicts confirmed EDSS progression by Merlo, Daniel, Stankovich, Jim, Bai, Claire, Kalincik, Tomas, Gresle, Melissa, Lechner-Scott, Jeannette, Kilpatrick, Trevor, Barnett, Michael, Taylor, Bruce, Darby, David, Butzkueven, Helmut, Walt, Anneke van der

“…ObjectivesTo identify and validate longitudinal reaction time trajectories in relapsing remitting multiple sclerosis using a computerised cognitive battery and…”
Get full text

010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort by Butzkueven, Helmut, Spelman, Tim, Kalincik, Tomas, Buzzard, Katherine, Walt, Anneke Van der, Lechner-Scott, Jeanette, Hodgkinson, Suzanne, Butler, Ernest, Macdonell, Richard, Slee, Mark, Group, MSBase Study, Marcel, Bruno

“…IntroductionOcrelizumab (OCR) is a humanised anti-CD20+ monoclonal antibody for the treatment of Multiple Sclerosis.ObjectivesIn Australian MSBase clinics, we…”
Get full text

008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis by Roos, Izanne, Malpas, Charles B, Leray, Emmanuelle, Buzzard, Katherine, Skibina, Olga, Lechner-Scott, Jeannette, McCombe, Pamela, Slee, Mark, Butler, Ernest, Macdonell, Richard, Walt, Anneke van der, Hodgkinson, Suzanne, Barnett, Michael, Vucic, Steve, Vukusic, Sandra, Butzkueven, Helmut, Kalincik, Tomas

“…ObjectivesTo evaluate the rate of return of disease activity after cessation of multiple sclerosis (MS) disease-modifying therapy.MethodsThis was a…”
Get full text

Serial Diffusion Tensor Imaging of the Optic Radiations after Acute Optic Neuritis by Egan, Gary F., Klistorner, Alexander, Butzkueven, Helmut, Walt, Anneke van der, Kolbe, Scott C., Kilpatrick, Trevor J.

“…Previous studies have reported diffusion tensor imaging (DTI) changes within the optic radiations of patients after optic neuritis (ON). We aimed to study…”
Get full text

004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis by Yeh, Wei Z, Widyastuti, Putu A, Walt, Anneke Van der, Stankovich, Jim, Havrdova, Eva K, Horakova, Dana, Vodehnalova, Karolina, Ozakbas, Serkan, Eichau, Sara, Duquette, Pierre, Kalincik, Tomas, Patti, Francesco, Boz, Cavit, Terzi, Murat, Yamout, Bassem, Lechner-Scott, Jeannette, Sola, Patrizia, Skibina, Olga, Barnett, Michael, Onofrj, Marco, Sá, Maria J, McCombe, Pamela, Grammond, Pierre, Ampapa, Radek, Grand’Maison, Francois, Bergamaschi, Roberto, Spitaleri, Daniele LA, Pesch, Vincent Van, Cartechini, Elisabetta, Hodgkinson, Suzanne, Soysal, Aysun, Saiz, Albert, Gresle, Melissa, Uher, Tomas, Maimone, Davide, Turkoglu, Recai, Hupperts, Raymond MM, Amato, Maria Pia, Granella, Franco, Oreja-Guevara, Celia, Altintas, Ayse, Macdonell, Richard, Castillo-Trivino, Tamara, Butzkueven, Helmut, Alroughani, Raed, Jokubaitis, Vilija G, Registry, MSBase

“…ObjectiveTo investigate pregnancy-related disease activity in a contemporary multiple sclerosis (MS) cohort.MethodsData were obtained from the MSBase Registry…”
Get full text

Addressing the treatment gap in MS-associated tremor: A new door opens by van der Walt, Anneke

Get full text

Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement by Reyes, Saúl, Cunningham, Anthony L., Kalincik, Tomas, Havrdová, Eva Kubala, Isobe, Noriko, Pakpoor, Julia, Airas, Laura, Bunyan, Reem F., van der Walt, Anneke, Oh, Jiwon, Mathews, Joela, Mateen, Farrah J., Giovannoni, Gavin

“…In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period…”
Get full text